A detailed history of All Square Wealth Management LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, All Square Wealth Management LLC holds 625 shares of EDIT stock, worth $818. This represents 0.0% of its overall portfolio holdings.

Number of Shares
625
Previous 625 -0.0%
Holding current value
$818
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 27, 2023

SELL
$6.92 - $9.31 $6,228 - $8,379
-900 Reduced 59.02%
625 $4,000
Q4 2021

Feb 08, 2022

SELL
$26.55 - $40.57 $1,062 - $1,622
-40 Reduced 2.56%
1,525 $40,000
Q2 2021

Aug 13, 2021

SELL
$31.29 - $56.64 $9,387 - $16,992
-300 Reduced 16.09%
1,565 $89,000
Q1 2021

May 11, 2021

BUY
$39.71 - $90.58 $15,884 - $36,232
400 Added 27.3%
1,865 $78,000
Q4 2020

Feb 09, 2021

SELL
$27.07 - $84.35 $5,684 - $17,713
-210 Reduced 12.54%
1,465 $103,000
Q3 2020

Nov 16, 2020

BUY
$28.06 - $37.16 $645 - $854
23 Added 1.39%
1,675 $47,000
Q2 2020

Aug 11, 2020

BUY
$18.5 - $34.34 $18,074 - $33,550
977 Added 144.74%
1,652 $49,000
Q3 2019

Nov 06, 2019

BUY
$22.49 - $26.81 $1,124 - $1,340
50 Added 8.0%
675 $15,000
Q1 2019

May 07, 2019

BUY
$19.43 - $26.41 $11,658 - $15,846
600 Added 2400.0%
625 $15,000
Q1 2018

May 11, 2018

SELL
$29.84 - $44.08 $746 - $1,102
-25 Reduced 50.0%
25 $1,000
Q4 2017

Feb 13, 2018

SELL
$21.89 - $31.34 $2,210 - $3,165
-101 Reduced 66.89%
50 $2,000
Q3 2017

Nov 06, 2017

BUY
$15.81 - $24.01 $2,387 - $3,625
151
151 $4,000

Others Institutions Holding EDIT

About Editas Medicine, Inc.


  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $90M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track All Square Wealth Management LLC Portfolio

Follow All Square Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of All Square Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on All Square Wealth Management LLC with notifications on news.